Yaz, Yasmin Lawsuits Filed in Indiana
The popular birth control pills, Yaz and Yasmin, have been linked to a wide array of adverse health effects. Now, over 50 more women have alleged in lawsuits that they suffered strokes, heart attacks, and a variety of other significant health problems as a result of taking the medications, said the IndyStar.
These lawsuits were filed in Indianapolis. Scores of others have been filed nationwide by dozens of women over the past recent months, said IndyStar; all claim similar problems. Plaintiffs allege Yaz was not subjected to adequate testing, and that Bayer failed to provide adequate warnings about its potential side effects. According to Bayer, Yaz and Yasmin are safe when used according to directions; furthermore, said Bayer, all oral contraceptives contain warnings for potential side effects, said the IndyStar. More Yaz, Yasmin Lawsuits Filed in Indiana
Progress in Yaz, Yasmin MDL
The multidistrict litigation involving Yaz and Yasmin is moving ahead. At a recent status conference, the judge overseeing the litigation discussed the establishment of "bellwether" trials with attorneys for both plaintiffs and defendants.
Yaz and Yasmin and a generic birth control pill called Ocella are all made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body's potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems. Adverse Events reported to the Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyponatremis, hyperkalemia, hyperkalemic arrhythmias, atrial fibrillation, tachycardia, bradycardia, myocardial infarction, stroke, transient ischemic attack, blood clots, embolisms, and sudden death. More Progress in Yaz, Yasmin MDL
More Yaz, Yasmin Lawsuits Filed
A half dozen more Yaz and Yasmin lawsuits have been filed by young women and their families who claim the popular birth control pills caused them to suffer blood clots and other serious health problems.
Yaz and Yasmin are both made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body's potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems. Adverse Events reported to the Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyponatremis, hyperkalemia, hyperkalemic arrhythmias, atrial fibrillation, tachycardia, bradycardia, myocardial infarction, stroke, transient ischemic attack, blood clots, embolisms, and sudden death. More More Yaz, Yasmin Lawsuits Filed
More Yaz Lawsuits Expected
Yaz lawsuits could soon number in the thousands, according to lawyers interviewed for a recent Washington Times report. Yaz lawsuits claim the popular contraceptive carries a higher risk of blood clots, heart attacks and strokes, than other birth control pills.
Yaz contains a synthetic type of progestin called drospirenone. Exposure to drospirenone can lead to hyperkalemia, a condition caused by excessive amounts of potassium in the blood, in high risk patients. This condition may result in potentially serious heart and health problems. Because of this risk, women with conditions that predispose them to hyperkalemia (such as renal insufficiency, hepatic dysfunction and adrenal insufficiency) should not take YAZ. Women taking YAZ must also be concerned about the drug interactions that could increase potassium. More More Yaz Lawsuits Expected
PA Woman Says Yaz Nearly Killed Her Daughter
Yaz, Bayer Healthcare's popular birth control pill, has been blamed for causing several pulmonary emboli that nearly killed a 16-year-old Pennsylvania girl. The young woman's mother has filed a personal injury lawsuit against Bayer on her daughter's behalf, alleging that Yaz was responsible for her daughter's severe and lasting injuries.
More than 100 lawsuits have been filed by women across the United States who claim they suffered strokes, pulmonary emboli, deep vein thrombosis, blood clots, gallbladder disease, and other serious injuries after taking Yaz, or its precursor, Yasmin. On October 1, 2009, all Yaz and Yasmin lawsuits pending in federal court were consolidated for centralized and coordinated pre-trial proceedings in the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation in the United States District Court for the Southern District of Illinois before Judge Herndon (MDL No. 2100). More PA Woman Says Yaz Nearly Killed Her Daughter
FDA Pondering New Internet Rules For Drug, Device Makers
The U.S. Food and Drug Administration (FDA) is looking into whether or not revised regulations are called for regarding how information is delivered on medicines and medical devices via the Internet, says Reuters. The meeting is entitled "Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media," and was announced in September.
Companies and consumer groups will be voicing opinions in a two-day meeting that began today. The focus of the meeting is on if Internet drug advertising requires "special oversight," said Reuters. To start, the Pharmaceutical Research and Manufacturers of America, an industry group, is working to have the FDA agree to a safety logo that would appear on Internet information and would also be linked to FDA-approved information about the device or medication, said Reuters. More FDA Pondering New Internet Rules For Drug, Device Makers
Yaz, Yaz Litigation Progresses, Plaintiffs' Steering Committee Named
There is progress to report in the Yaz and Yasmin multidistrict litigation (MDL No. 2100) currently underway in U.S. District Court for the Southern District of Illinois. Judge David Herndon, who is overseeing the Yaz and Yasmin MDL, has appointed members to the Plaintiffs' Steering Committee. One of those appointed by Judge Herndon is Andres F. Alonso, Esq., a partner in the law firm of Parker Waichman Alonso LLP.
As we've reported previously, Mr. Alonso also serves as Co-Lead Counsel in the Denture Cream Liability Litigation (MDL No. 2051) currently pending before Honorable Judge Cecilia Altonaga in the United States District Court for the Southern District of Florida, Miami Division. More Yaz, Yaz Litigation Progresses, Plaintiffs' Steering Committee Named
Yaz, Yasmin Lawsuits in New Jersey Could be Deemed Mass Tort
This year, the U.S. Food and Drug Administration (FDA) mandated Bayer—maker of the birth control pill, Yaz—to run a correction to its Yaz marketing that cost some $20-million. Bayer must also submit its ads to the agency for approval resulting from a legal settlement obtained by some state attorneys general and the agency.
Now, Yaz and Yasmin lawsuits originating in New Jersey might be deemed a mass tort. According to Law.com, a Passaic County request is being considered by the judiciary in that state for the mass tort status. More Yaz, Yasmin Lawsuits in New Jersey Could be Deemed Mass Tort
Yaz Faces Swiss Probe Following User's Sudden Death
Swiss health regulators are investigating Yaz following the "sudden" death of a young women who suffered a pulmonary emboli while taking the popular birth control pill.
Yaz was approved in the U.S. in 2006. It is a low-estrogen pill, and is made with a type of progestin called drospirenone. As we've reported previously, drospirenone is known to carry some health risks not seen with other forms of the hormone. Most notably, it can increase the levels of potassium in the blood, which can lead to a disorder called hyperkalemia in high risk patients. This condition may result in potentially serious heart and health problems, including fatal cardiac arrhythmias. High potassium levels are especially dangerous for people who are obese, or who have diabetes or high blood pressure. More Yaz Faces Swiss Probe Following User's Sudden Death
Yaz and Yasmin Legal Woes Mount for Bayer
Bayer Healthcare is facing a raft of legal troubles over its popular birth control pills, Yaz and Yasmin. According to The New York Times, at least 74 lawsuits have been filed by women who claim either Yaz or Yasmin caused health problems, including heart attacks, strokes and blood clots.
Yasmin and Yaz are both low estrogen oral contraceptives. Yasmin was approved in the U.S. in 2001, while Yaz, which contains even less estrogen, was approved in 2006. Together, the pills generated about $1.8 billion last year for Bayer HealthCare, which according to The New York Times, has positioned them as the "go-to drug brands for women under 35." Yaz, which is the top-selling birth control pill in the U.S., has been marketed by Bayer as "a quality-of-life treatment to combat acne and severe premenstrual depression," the Times said. More Yaz and Yasmin Legal Woes Mount for Bayer
0 comments:
Post a Comment